Kymera Therapeutics shares owned by Propel Bio Management
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Propel Bio Management
from 13F filings
Historical chart of Propel Bio Management investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Kymera Therapeutics by Propel Bio Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1.4M | 56k | 25.46 |